Process for producing pravastatin sodium salt using streptomyces flavidovirens dsm 14455

Citations
2004/0253692 2004/0259216 2005/0064566 4448979 5179013 6043064
Suggestions

If you were to search for Process for producing pravastatin sodium salt using streptomyces flavidovirens dsm 14455 using relaxed search criteria, these patents would come up:

Patent number     Title Issue date
6183513 Intraocular lens packaging system, method of producing, and method of using 2001-02-06
6183664 Deicing and snow-removing composition, method for producing the same, and use thereof 2001-02-06
6187231 Process for producing polymeric films for use as fuel cells 2001-02-13
6187308 Monoclonal antibodies against leukocyte adhesion receptor .beta.-chain, methods of producing these antibodies and use therefor 2001-02-13
6187367 Low viscosity meat emulsion and process for producing a protein composition useful to form a low viscosity meat emulsion 2001-02-13
6187741 Process for preparing saturated lactones, products produced therefrom and organoleptic uses of said products 2001-02-13
6187880 Process for producing an olefin polymer using a metallocene 2001-02-13
6207123 Process for producing sodium salts 2001-03-27
6306629 Microorganism streptomyces exfoliatus yj-118 and a method for producing pravastatin sodium by using the strain 2001-10-23
6444662 Stable hyperforin salts, method for producing same and their use in the treatment of alzheimer's disease 2002-09-03
6576209 Process for producing sodium salts 2003-06-10
6624143 Calcium salts of lipopeptide antibiotics, method for producing same and their use 2003-09-23
7067476 Peptide derivative, and pharmaceutically acceptable salt thereof, process for producing the same, and use thereof 2006-06-27
7078558 Crystals of the sodium salt of pravastatin 2006-07-18
6706249 Composite polybasic salt, process for producing the same, and use 2004-03-16
6716615 Strains of saccharaothrix, process for producing pravastatin using the strains and isolation process of (HMG)-CoA reductase 2004-04-06
6740775 Crystalline sodium salt of pravastatin 2004-05-25
6835320 Zinc-modified composite polybasic salt, process for producing the same, and use 2004-12-28
6906220 Process to produce 4-(2-sulfoethyl) cyclohexane, 1,2-diol sodium salt from 4-vinylcyclohexane-1,2-diol 2005-06-14
7189558 Process for producing pravastatin sodium salt using streptomyces flavidovirens dsm 14455 2007-03-13
Claims:

We claim:

1. A strain of Strepomyces flavidovirens deposited at Deutsche Sammlung von Mikro-organismen und Zelikulturen GmbH under accession number DSM 14455.

2. A microbial process for preparing a compound of formula I ##STR00003## from a substrate compound of general formula II, ##STR00004## wherein R represents an alkali metal or ammonium ion, comprising steps of (i) preparing a seed inoculum of astrain of Streptomyces flavidovirens that 6.beta.-hydroxylates a compound of formula II, (ii) transferring the seed inoculum to a production medium, (iii) subjecting the production medium to fermentation, (iv) feeding a substrate of Formula II in theproduction medium at different intervals, (v) controlling the pH during fermentation by feeding a carbon source in the production medium, (vi) fermenting the substrate until bioconversion to Pravastatin is complete, (vii) extracting Pravastatin from theproduction medium, and (viii) isolating Pravastatin sodium salt.

3. The process of claim 2, wherein the strain of Streptomyces flavidovirens is the Strepbomyces flavidovirens strain deposited with DSMZ (Deutsche Sammlung von Mikro-organismen und Zellkulturen GmbH) under accession number DSMZ 14455.

4. The process of claim 2 wherein the inoculum used for the seed is a spore suspension or a vegetative mycelium.

5. The process of claim 2 wherein the substrate is compactin, a compactin salt or a compactin derivative.

6. The process of claim 2 wherein the seed inoculum comprises malt extract and peptone.

7. The process of claim 2 further comprising a step of incubating the seed inoculum.

8. The process of claim 7 wherein the seed medium is incubated between about 25 and 35.degree. C. for about 40 to 55 hours.

9. The process of claim 2 wherein constituents of the production medium are selected from the group consisting of dextrose monohydrate, peptone and yeast extract.

10. The process of claim 2 further comprising a step of incubating the production medium.

11. The process of claim 10 wherein the production medium is incubated between about 24 and 35.degree. C. for about 48 to 148 hours.

12. The process of claim 2 wherein the carbon source is selected from a saccharide or glycerol.

13. The process of claim 12 wherein the carbon source is dextrose.

14. The process of claim 2 wherein the step of isolating Pravastatin sodium salt comprises converting Pravastatin isolated from the cell broth to its dibenzylamide salt.

15. The process of claim 14 wherein the dibenzylamide salt is converted to Pravastatin sodium salt by reaction with sodium caprylate.

16. The process of claim 2 wherein in the step of extracting Pravastatin from the whole cell broth, Pravastatin is obtained in its lactone form.

17. The process of claim 2 wherein in the step of extracting Pravastatin from the whole cell broth, Pravastatin is obtained as its lactone form, and the step of isolating Pravastatin sodium salt comprises converting the lactone to Pravastatinacid.

18. The process of claim 17 wherein converting the lactone to Pravastatin acid comprises contacting the lactone with a methanolic solution of sodium hydroxide.

19. The process of claim 17 wherein Pravastatin acid is further converted to Pravastatin sodium salt by reaction with sodium caprylate.

20. The process of claim 17 wherein Pravastatin acid is further converted to Pravastatin sodium salt by reaction with sodium acetate.

21. The process of claim 17 wherein Pravastatin acid is further converted to Pravastatin dibenzylamide salt by reaction with dibenzylamine.

22. The process of claim 21 wherein Pravastatin dibenzylamide salt is further converted to Pravastatin sodium salt by reaction with sodium caprylate.

23. A composition comprising a strain Streptomyces flavidovirens DSM 14455 and compactin, a compactin salt or a compactin derivative.

Patent number:
    7189558
View patent at USPTO

Filing date:
    September 27, 2001

Issue date:
    March 13, 2007

Inventors:
Madhavan Sridharan (Karnataka, IN)
Acharya Poornaprajna (Karnataka, IN)
Sambasivam Ganesh (Karnataka, IN)
Shrikumar Suryanarayan (Karnataka, IN)
Ramavana Gururaja (Karnataka, IN)
Anuj Goel (Karnataka, IN)
Ramakrishnan Sadhana Melarkode (Karnataka, IN)
Madhav Kulkarni (Maharashtra, IN)
Deepthy Sathyanathan (Karnataka, IN)

Primary Examiner:
Ralph Gitomer

Attorney, Agent or Firm:
Robidoux; Andrea L. C.Choate, Hall & Stewart LLP

Current U.S. Classification: 435/253.5 435/886 549/292 560/179

Email: contact@findthatpatent.com | © 2007 Dream Ratings | About

cool hit counter


example: magnesium alloy,  or: 6652852,  or: Jeffrey A. Ledbetter (inventor),  or whatever